• Linkedin
  • Twitter
  • Youtube
  • Facebook
  • Instagram
HCS Pharma
  • Company
    • About us
    • Team
    • Scientific Advisory Board
    • Advisory Board
    • R&D programs and partnerships
      • MIMLIVEROnChip
      • NEUROCELL3D
      • ONCO3D
      • VisuAI
    • Pressroom
      • Press releases
      • Photos for the press
      • HCS Pharma in press
    • Labels, prizes and distinctions
    • Partners and Memberships
    • Privacy Policy
  • BIOMIMESYS®
    • What is BIOMIMESYS® hydroscaffold?
    • BIOMIMESYS® Brain
    • BIOMIMESYS® Liver
    • BIOMIMESYS® Adipose tissue
    • BIOMIMESYS® Oncology
    • BIOMIMESYS® Custom
    • How to buy BIOMIMESYS®?
  • Assay Services
    • Dermocosmetology
      • Anti-Aging
      • Slimming
      • Anti-Oxidant
      • Anti-Redness
      • Wound Healing
      • Skin Pigmentation
      • Anti-Pollution
      • Skin Microbiota
      • Custom Your Assay In Dermocosmetics
    • Pharmacology
      • 3D Screening against Liver Cancer
      • 3D Anti-colon Cancer Drug Assessment
      • Custom Your 3D Phenotypic Assay In Oncology
      • 3D Parkinson’s Disease
      • Migration
      • Cell cycle arrest
    • Toxicology
      • 3D Neurotoxicity Assessment
  • Ressources
    • Publications – Scientific articles
    • Application Notes
    • Conferences & Webinars
    • News
    • Posters
    • Brochures
    • BIOMIMESYS® tutorials
    • Customer testimonials
    • Certificates of Analysis
    • TDS&MSDS
    • Protocols
    • Frequently Asked Questions
    • Christmas 2023 giveaway contest
  • Contacts
    • How to contact us?
    • How to buy BIOMIMESYS®?
    • Subscribe to our Newsletter
    • Join Us

Thomas Meynard

Biomimesys

The importance of extracellular matrix in cancers

The extracellular matrix (ECM) is the non-cellular component of tissue. Its composition and structure can vary between different tissues. The ECM transmits biochemical and biomechanical cues to the cells within it, ensuring tissue homeostasis. The ECM is a dynamic structure whose composition and organization can be modified as in the Read more…

By Thomas Meynard, 3 yearsApril 20, 2021 ago
HCS, HCA & Biology

Towards better in vitro models : example of vascularized tumor-on chip

In 2018, the World Health Organization announced 9.6 million deaths due to cancer, worldwide. Concerning the cancer cost, it was estimated to be more than US$ 1.16 trillion. For these reasons, developing more effective anti-cancer molecules is primordial. Unfortunately, despite the large number of molecules tested, 43% of failure occurs Read more…

By Thomas Meynard, 3 yearsNovember 10, 2020 ago
  • Company
  • BIOMIMESYS®
  • Assay Services
  • Ressources
  • Contacts
HCS Pharma (c) 2021 | Hestia | Powered by WordPress
 

Loading Comments...